Xbrane Biopharma: Interview with CEO Martin Åmark
23 juni, 11:35
23 juni, 11:35
Redeye interviews Xbrane’s CEO, Martin Åmark. We discuss the recent directed share issue, expectations for Ximluci and Xdivane and how the investment case has evolved following the partnership with Alvotech.
23 juni, 11:35
Redeye interviews Xbrane’s CEO, Martin Åmark. We discuss the recent directed share issue, expectations for Ximluci and Xdivane and how the investment case has evolved following the partnership with Alvotech.
Aktierekommendationer
Oljepriset
Aktierekommendationer
Oljepriset
1 DAG %
Senast
Swedbank Robur Global Emerging Markets A
Igår, 15:13
Förvaltaren gör comeback i Japanfonden – Barnevik lämnar
VEF
Igår, 14:01
VEF: Det hänger på Creditas
OMX Stockholm 30
1 DAG %
Senast
2 452,44